Our Latest News - BUHLMANN

BUHLMANN News

The New Biosimilar of IFX SB2 Can be Quantified by IFX-Optimized Therapeutic Drug Monitoring Assays

BÜHLMANN Quantum Blue® IFX Citation: Magro, F., Rocha, C. et al. P229 The new biosimilar of IFX SB2 can be quantified by IFX-optimized therapeutic drug monitoring assays.  Journal of Crohns and Colitis.  2018, Jan. DOI: 10.1093/ecco-jcc/jjx180.356. BÜHLMANN Quantum Blue® IFX is for Research Use Only in the US.  Not for use in diagnostic procedures in the US. Health
Continue Reading

A Pilot Study Using Point of Care Testing for IFX and Faecal Calprotectin in IBD Patients

BÜHLMANN Quantum Blue® IFX Citation: Sophie Restellini, Talat Bessissow, Carolyne Lemieux, Che-Yung Chao, Gary Wild, Ernest Seidman, Alain Bitton, Peter L. Lakatos, Waqqas Afif.  P711 A pilot study using point of care testing for IFX and faecal calprotectin in IBD patients with a secondary loss of response.  Journal of Crohn's and Colitis. 2018 Jan. DOI: 10.1093/ecco-jcc/jjx180.838. Highlight from
Continue Reading

The Clinical Utility of Basophil Activation Testing in Diagnosis and Monitoring of Allergic Disease

Chronic Urticaria and BAT Guidelines: Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo DG, Sabato V, Sanz ML, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015 Nov;70(11):1393-405. Epub
Continue Reading

The EAACI/GA(2) LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis, and Management of Urticaria

Chronic Urticaria and BAT Guidelines: Zuberbier T, et al;; European Academy of Allergy and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014 Jul;69(7):868-87.  Epub 2014 Apr 30. PubMed PMID:
Continue Reading

Functional and Phenotypic Analysis of Basophils Allows Determining Distinct Subtypes in Patients with Chronic urticaria

Flow CAST® Assay: Rauber MM, Pickert J, Holiangu L, Möbs C, Pfützner W. Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria. Allergy. 2017 Dec;72(12):1904-1911. . Epub 2017 Jul 12. PubMed PMID: 28585360; doi:10.1111/all.13215 Highlights from this Publication “CU can be categorized into three immunologic subgroups based on their basophil
Continue Reading

BUHLMANN LabSense News Winter 2018 Edition

BUHLMANN Diagnostics Corp is proud to release the sixth edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Check Out LabSense News Today! What's New Introducing BAT in Food Allergy Webinar recording and eBook by Dr. Alexandra Santos as well as two new IBDoc®  Posters
Continue Reading

Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity

Flow CAST® Assay:   Netchiporouk E, Moreau L, Rahme E, Maurer M, Lejtenyi D, Ben-Shoshan M. Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity. Int Arch Allergy Immunol. 2016;171(2):81-88. Epub 2016 Nov 16. PubMed PMID:27846634; doi:  10.1159/000451084. Highlights from this Publication “Our study provides, for the
Continue Reading

IBDoc Highlights

Health Canada Licence: 98903, Device class: 3  IBDoc® is not available for sale in the US. IBDoc® Calprotectin Home Test Video IBDoc®  Highlights Learn more about this calprotectin home test and check out the IBDoc®  highlights including key features, studies, posters, citations, videos, informational flyers and more! Three Easy Steps to Help Monitor IBD IBDoc® is the first
Continue Reading

Basophil Activation Test Identifies the Patients with Chronic Spontaneous Urticaria Suffering the Most Active Disease

Flow CAST® Assay: Curto-Barredo L, Yelamos et al. Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease. Immun Inflamm Dis. 2016 Oct 4;4(4):441-445. eCollection 2016 Dec. PubMed PMID: 27980778; doi:  10.1002/iid3.125. Highlights from this Publication “BAT was performed, measuring expression of the CD63 surface marker on basophils from whole blood by
Continue Reading

The Advantages of an Immunoturbidimetric Assay for Measuring Calprotectin in Fecal Samples

 Technical Details Speed An immunoturbidimetric assay (or particle-enhanced turbidimetric immunoassay (PETIA)) for measuring Calprotectin is the fastest solution in the market with the shortest time to first result regardless of using sample batches or random access. On average, the time to first result is 7.6 min [5 min -11.6 min] with additional results every 10.86
Continue Reading